COMPOSITIONS AND METHODS OF TREATING T CELL MEDIATED DISORDER

• 收藏
• 分享

专利权人:

发明人:

M. Edward Medof,Feng Lin

申请号：

US15077256

公开号：

US20170014451A1

申请日:

2016.03.22

申请国别(地区):

US

年份:

2017

代理人:

摘要：

A method of generating a CD4+FoxP3+ Treg cell, the method includes administering at least one complement antagonist to a naive CD4+ T cell at an amount effective to substantially inhibits C3a receptor (C3aR) and/or C5a receptor (C5aR) signal transduction in the CD4+ T cell, induce TGF-β1 expression of the CD4+ T cell, and induce differentiation of the of the naive CD4+ T cell into a CD4+FoxP3+ Treg cell.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/